Suppr超能文献

粪便免疫化学检测样本采集技术的变异性对临床性能的影响。

The Effect of the Variability in Fecal Immunochemical Test Sample Collection Technique on Clinical Performance.

机构信息

Bowel Health Service, Flinders Medical Center, Bedford Park, South Australia, Australia.

Cancer Research, Flinders Health and Medical Research Institute, Flinders University, Bedford Park, South Australia, Australia.

出版信息

Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):175-181. doi: 10.1158/1055-9965.EPI-20-0984. Epub 2020 Oct 12.

Abstract

BACKGROUND

Fecal immunochemical test (FIT) performance can be affected by post-collection variables. Collection technique might also affect fecal hemoglobin concentration (f-Hb). Variation in quantity of feces collected in samples returned in a colorectal cancer detection program, and the effects of under-sampling, were assessed.

METHODS

Collection devices obtained from patients undergoing FIT were assessed for the color (in five classes) of the feces in buffer, mass, and f-Hb. Associations between these were examined in an study on Hb-spiked feces. Variables possibly associated with under-sampling were investigated using multivariable logistic regression. The effect of low sample mass on clinical performance (false-negative results) was determined.

RESULTS

Of 6,898 samples collected by 3,449 individuals (46.9% male, median age: 65.3 years), the buffer was lightest in color in 362 (5.2%), and darkest in 420 (6.1%). Samples with the lightest color had a significantly lower f-Hb compared with all darker classes ( < 0.001). Mass was recorded for 650 devices: The lightest colored samples had significantly lower mass ( < 0.05). The correlation between mass and f-Hb was confirmed ( = 0.897, < 0.001). Low mass was not associated with age, sex, or technical factors ( > 0.05). Under-sampling related to the lightest color was not associated with false-negative results for colorectal cancer and advanced adenoma, but was for all neoplasia and inflammatory bowel disease.

CONCLUSIONS

Wide variation existed in the amount of feces collected. Under-sampling results in lower measured f-Hb and may increase false-negative results.

IMPACT

Color of sample buffer could be used to identify inadequate sampling.

摘要

背景

粪便免疫化学检测(FIT)的性能可能会受到采集后变量的影响。采集技术也可能会影响粪便血红蛋白浓度(f-Hb)。本研究评估了在结直肠癌检测项目中返回的样本中采集粪便量的变化,以及采集量不足的情况及其影响。

方法

评估了从接受 FIT 检查的患者中获得的采集装置,以评估缓冲液中粪便的颜色(分为 5 个等级)、质量和 f-Hb。在一项关于血红蛋白加标粪便的研究中,研究了这些变量之间的关系。使用多变量逻辑回归调查了与采集量不足相关的可能变量。确定了低样本量对临床性能(假阴性结果)的影响。

结果

在 3449 名个体(46.9%为男性,中位年龄:65.3 岁)采集的 6898 个样本中,362 个(5.2%)缓冲液颜色最浅,420 个(6.1%)最深。颜色最浅的样本 f-Hb 明显低于所有较深等级(<0.001)。记录了 650 个装置的质量:颜色最浅的样本质量明显较低(<0.05)。质量与 f-Hb 之间的相关性得到了证实(r=0.897,<0.001)。低质量与年龄、性别或技术因素无关(>0.05)。与最浅颜色相关的采集量不足与结直肠癌和高级腺瘤的假阴性结果无关,但与所有肿瘤和炎症性肠病的假阴性结果有关。

结论

采集粪便的量存在广泛的差异。采集量不足会导致测量的 f-Hb 降低,可能会增加假阴性结果。

意义

样本缓冲液的颜色可用于识别采集不足的情况。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验